|
🐜
|
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
15 auth.
J. Ledermann,
P. Harter,
C. Gourley,
M. Friedlander,
I. Vergote,
G. Rustin,
C. Scott,
W. Meier,
R. Shapira-Frommer,
T. Safra,
...
D. Matei,
E. Macpherson,
C. Watkins,
J. Carmichael,
U. Matulonis
|
10 |
2012 |
10
🐜
|
|
🐬
|
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
A. du Bois,
A. Reuss,
E. Pujade-Lauraine,
P. Harter,
I. Ray-Coquard,
J. Pfisterer
|
10 |
2009 |
10
🐬
|
|
🐜
|
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
20 auth.
E. Pujade-Lauraine,
J. Ledermann,
F. Selle,
V. Gebski,
R. Penson,
A. Oza,
J. Korach,
T. Huzarski,
A. Poveda,
S. Pignata,
...
M. Friedlander,
N. Colombo,
P. Harter,
K. Fujiwara,
I. Ray-Coquard,
Susana Banerjee,
Joyce F. Liu,
E. Lowe,
R. Bloomfield,
P. Pautier
|
10 |
2017 |
10
🐜
|
|
🐢
|
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
30 auth.
I. Ray-Coquard,
P. Pautier,
S. Pignata,
D. Pérol,
A. González-Martín,
R. Berger,
K. Fujiwara,
I. Vergote,
N. Colombo,
J. Mäenpää,
F. Selle,
J. Sehouli,
D. Lorusso,
E. G. Guerra Alía,
A. Reinthaller,
...
S. Nagao,
C. Lefeuvre-Plesse,
U. Canzler,
G. Scambia,
A. Lortholary,
F. Marmé,
P. Combe,
N. de Gregorio,
M. Rodrigues,
P. Buderath,
C. Dubot,
A. Burges,
B. You,
E. Pujade-Lauraine,
P. Harter
|
10 |
2019 |
10
🐢
|
|
🐜
|
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
18 auth.
J. Ledermann,
P. Harter,
C. Gourley,
M. Friedlander,
I. Vergote,
G. Rustin,
Clare L Scott,
W. Meier,
R. Shapira-Frommer,
T. Safra,
...
D. Matei,
A. Fielding,
S. Spencer,
B. Dougherty,
M. Orr,
D. Hodgson,
J. C. Barrett,
U. Matulonis
|
10 |
2014 |
10
🐜
|
|
🐜
|
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
159 auth.
G. Chornokur,
Hui-Yi Lin,
J. Tyrer,
K. Lawrenson,
J. Dennis,
E. Amankwah,
Xiaotao Qu,
Ya‐Yu Tsai,
H. Jim,
Zhihua Chen,
Ann Chen,
Jennifer Permuth‐Wey,
K. Aben,
H. Anton-Culver,
N. Antonenkova,
...
F. Bruinsma,
E. Bandera,
Yukie T. Bean,
M. Beckmann,
Maria Bisogna,
L. Bjørge,
N. Bogdanova,
L. Brinton,
A. Brooks-Wilson,
C. Bunker,
R. Butzow,
I. Campbell,
K. Carty,
J. Chang-Claude,
L. Cook,
D. Cramer,
J. Cunningham,
C. Cybulski,
A. Dansonka-Mieszkowska,
A. du Bois,
E. Despierre,
E. Dicks,
J. Doherty,
T. Dörk,
M. Dürst,
D. Easton,
D. Eccles,
R. Edwards,
A. Ekici,
P. Fasching,
B. Fridley,
Yu-Tang Gao,
A. Gentry-Maharaj,
G. Giles,
R. Glasspool,
M. Goodman,
J. Gronwald,
P. Harrington,
P. Harter,
A. Hein,
F. Heitz,
M. Hildebrandt,
P. Hillemanns,
C. Høgdall,
E. Høgdall,
S. Hosono,
A. Jakubowska,
A. Jensen,
B. Ji,
B. Karlan,
L. Kelemen,
Mellissa Kellar,
L. Kiemeney,
C. Krakstad,
S. Kjaer,
J. Kupryjańczyk,
D. Lambrechts,
S. Lambrechts,
N. Le,
Alice W. Lee,
S. Lele,
A. Leminen,
J. Lester,
D. Levine,
Dong Liang,
B. Lim,
J. Lissowska,
K. Lu,
J. Lubiński,
L. Lundvall,
L. Massuger,
K. Matsuo,
V. McGuire,
J. McLaughlin,
I. McNeish,
U. Menon,
R. Milne,
F. Modugno,
K. Moysich,
R. Ness,
H. Nevanlinna,
U. Eilber,
K. Odunsi,
S. Olson,
I. Orlow,
S. Orsulic,
R. P. Weber,
J. Paul,
C. Pearce,
T. Pejovic,
Liisa M. Pelttari,
M. Pike,
E. Poole,
H. Risch,
B. Rosen,
M. Rossing,
J. Rothstein,
A. Rudolph,
I. Runnebaum,
I. Rzepecka,
H. Salvesen,
E. Schernhammer,
I. Schwaab,
X. Shu,
Yurii B. Shvetsov,
N. Siddiqui,
W. Sieh,
Honglin Song,
M. Southey,
B. Śpiewankiewicz,
Lara E. Sucheston,
S. Teo,
K. Terry,
P. Thompson,
L. Thomsen,
I. L. Tangen,
S. Tworoger,
A. van Altena,
R. Vierkant,
I. Vergote,
C. Walsh,
S. Wang-gohrke,
N. Wentzensen,
A. Whittemore,
K. Wicklund,
L. Wilkens,
A. Wu,
Xifeng Wu,
Y. Woo,
Hannah P. Yang,
W. Zheng,
A. Ziogas,
H. Hasmad,
A. Berchuck,
E. Iversen,
J. Schildkraut,
S. Ramus,
E. Goode,
A. Monteiro,
S. Gayther,
S. Narod,
P. Pharoah,
T. Sellers,
C. Phelan
|
9 |
2015 |
9
🐜
|
|
🦁
|
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
19 auth.
P. Harter,
A. Bois,
M. Hahmann,
A. Hasenburg,
A. Burges,
Sibylle Loibl,
M. Gropp,
J. Huober,
D. Fink,
W. Schröder,
...
K. Muenstedt,
B. Schmalfeldt,
G. Emons,
J. Pfisterer,
K. Wollschlaeger,
H. Meerpohl,
G. Breitbach,
B. Tanner,
J. Sehouli
|
8 |
2006 |
8
🦁
|
|
🦁
|
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
28 auth.
P. Harter,
J. Sehouli,
D. Lorusso,
A. Reuss,
I. Vergote,
C. Marth,
Jae-Weon Kim,
F. Raspagliesi,
B. Lampe,
G. Aletti,
W. Meier,
D. Cibula,
A. Mustea,
S. Mahner,
I. Runnebaum,
...
B. Schmalfeldt,
A. Burges,
R. Kimmig,
G. Scambia,
S. Greggi,
F. Hilpert,
A. Hasenburg,
P. Hillemanns,
G. Giorda,
Ingo von Leffern,
C. Schade-Brittinger,
U. Wagner,
A. du Bois
|
8 |
2019 |
8
🦁
|
|
🐜
|
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
18 auth.
J. Ledermann,
P. Harter,
C. Gourley,
M. Friedlander,
I. Vergote,
G. Rustin,
C. Scott,
W. Meier,
R. Shapira-Frommer,
T. Safra,
...
D. Matei,
A. Fielding,
S. Spencer,
P. Rowe,
E. Lowe,
D. Hodgson,
M. Sovak,
U. Matulonis
|
8 |
2016 |
8
🐜
|
|
🐜
|
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
177 auth.
P. Pharoah,
Ya‐Yu Tsai,
S. Ramus,
C. Phelan,
E. Goode,
K. Lawrenson,
Melissa Buckley,
B. Fridley,
J. Tyrer,
Howard C. Shen,
R. P. Weber,
Rod Karevan,
M. Larson,
Honglin Song,
D. Tessier,
...
F. Bacot,
Daniel Vincent,
J. Cunningham,
J. Dennis,
E. Dicks,
K. Aben,
H. Anton-Culver,
N. Antonenkova,
Sebastian M. Armasu,
L. Baglietto,
L. Baglietto,
E. Bandera,
M. Beckmann,
M. Birrer,
G. Bloom,
N. Bogdanova,
J. Brenton,
L. Brinton,
A. Brooks-Wilson,
Robert Brown,
R. Bützow,
I. Campbell,
I. Campbell,
M. Carney,
Renato S. Carvalho,
J. Chang-Claude,
Y. A. Chen,
Zhihua Chen,
W. Chow,
M. Cicek,
G. Coetzee,
L. Cook,
D. Cramer,
C. Cybulski,
A. Dansonka-Mieszkowska,
E. Despierre,
J. Doherty,
T. Dörk,
A. Bois,
M. Dürst,
D. Eccles,
R. Edwards,
A. Ekici,
P. Fasching,
P. Fasching,
D. Fenstermacher,
J. Flanagan,
Yu-Tang Gao,
M. García-Closas,
A. Gentry-Maharaj,
G. Giles,
G. Giles,
G. Giles,
A. Gjyshi,
M. Gore,
J. Gronwald,
Qi Guo,
M. K. Halle,
P. Harter,
A. Hein,
F. Heitz,
P. Hillemanns,
M. Hoatlin,
E. Høgdall,
C. Høgdall,
S. Hosono,
A. Jakubowska,
A. Jensen,
K. Kalli,
B. Karlan,
Linda E. Kelemen,
Linda E. Kelemen,
L. Kiemeney,
S. Kjaer,
G. Konecny,
C. Krakstad,
J. Kupryjańczyk,
D. Lambrechts,
S. Lambrechts,
N. Le,
N. Lee,
Janet M. Lee,
A. Leminen,
B. Lim,
J. Lissowska,
J. Lubiński,
L. Lundvall,
G. Lurie,
L. Massuger,
K. Matsuo,
V. McGuire,
J. McLaughlin,
U. Menon,
F. Modugno,
K. Moysich,
T. Nakanishi,
S. Narod,
R. Ness,
H. Nevanlinna,
S. Nickels,
H. Noushmehr,
K. Odunsi,
S. Olson,
I. Orlow,
J. Paul,
T. Pejovic,
Liisa M. Pelttari,
Jennifer Permuth‐Wey,
M. Pike,
M. Pike,
E. Poole,
Xiaotao Qu,
H. Risch,
L. Rodriguez-Rodriguez,
M. Rossing,
M. Rossing,
A. Rudolph,
I. Runnebaum,
I. Rzepecka,
H. Salvesen,
I. Schwaab,
G. Severi,
G. Severi,
Hui Shen,
V. Shridhar,
X. Shu,
W. Sieh,
M. Southey,
P. Spellman,
K. Tajima,
Soo-Hwang Teo,
K. Terry,
P. Thompson,
A. Timorek,
S. Tworoger,
A. Altena,
D. V. Berg,
I. Vergote,
R. Vierkant,
A. Vitonis,
S. Wang-gohrke,
N. Wentzensen,
A. Whittemore,
E. Wik,
B. Winterhoff,
Y. Woo,
A. Wu,
Hannah P. Yang,
W. Zheng,
A. Ziogas,
Famida Zulkifli,
M. Goodman,
P. Hall,
D. Easton,
C. Pearce,
A. Berchuck,
G. Chenevix-Trench,
E. Iversen,
A. Monteiro,
S. Gayther,
J. Schildkraut,
T. Sellers
|
8 |
2013 |
8
🐜
|
|
🐢
|
Incorporation of pazopanib in maintenance therapy of ovarian cancer.
35 auth.
A. du Bois,
A. Floquet,
Jae-Weon Kim,
J. Rau,
J. D. Del Campo,
M. Friedlander,
S. Pignata,
K. Fujiwara,
I. Vergote,
N. Colombo,
M. Mirza,
B. Monk,
R. Kimmig,
I. Ray-Coquard,
R. Zang,
...
I. Díaz-Padilla,
K. Baumann,
M. Mouret-Reynier,
Jae-Hoon Kim,
C. Kurzeder,
A. Lesoin,
P. Vasey,
C. Marth,
U. Canzler,
G. Scambia,
M. Shimada,
P. Calvert,
E. Pujade-Lauraine,
Byoung-Gie Kim,
T. Herzog,
I. Mitrica,
C. Schade-Brittinger,
Qiong Wang,
R. Crescenzo,
P. Harter
|
8 |
2014 |
8
🐢
|
|
🐜
|
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy.
10 auth.
Lars Hanker,
S. Loibl,
N. Burchardi,
J. Pfisterer,
W. Meier,
E. Pujade-Lauraine,
...
I. Ray-Coquard,
J. Sehouli,
P. Harter,
A. D. Bois
|
8 |
2012 |
8
🐜
|
|
🦁
|
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer: The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO
20 auth.
P. Harter,
J. Sehouli,
A. Reuss,
A. Hasenburg,
G. Scambia,
D. Cibula,
S. Mahner,
I. Vergote,
A. Reinthaller,
A. Burges,
...
L. Hanker,
M. Pölcher,
C. Kurzeder,
U. Canzler,
K. Petry,
A. Obermair,
E. Petru,
B. Schmalfeldt,
D. Lorusso,
A. du Bois
|
8 |
2010 |
8
🦁
|
